We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hemogenyx Pharmaceuticals Plc | LSE:HEMO | London | Ordinary Share | GB00BYX3WZ24 | ORD GBP0.01 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.68% | 1.515 | 1.48 | 1.55 | 1.50 | 1.48 | 1.50 | 3,138,617 | 16:35:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 0 | -3.98M | -0.0035 | -4.23 | 16.9M |
Date | Subject | Author | Discuss |
---|---|---|---|
01/3/2024 11:58 | If it wasnt cancer wouldn't exist | saint in exile | |
01/3/2024 11:57 | I suggest you research some of the buy outs for T CAR companies in recent times.The sector is very much in its infancy | saint in exile | |
01/3/2024 11:35 | saint in exile 1 Mar '24 - 11:19 - 8806 of 8806 So what.You need funding to unlock this tech.who knew.Some of us are more interested in the end game and yes that involves placings and risk.You either take the chance or you dont.Its not like some kind of con trick.Vlad is really trying to save lives.Maybe even your mums Dreamyif you have one | apotheki | |
01/3/2024 11:19 | So what.You need funding to unlock this tech.who knew.Some of us are more interested in the end game and yes that involves placings and risk.You either take the chance or you dont.Its not like some kind of con trick.Vlad is really trying to save lives.Maybe even your mums Dreamyif you have one | saint in exile | |
01/3/2024 08:30 | Orchestralis 29 Feb '24 - 21:34 - 8802 of 8804 I'm not sure what people expect. This is an early stage pharma with no revenue currently. They have to raise money through the markets to fund research and development. Why is that so surprising/disappoin | apotheki | |
29/2/2024 23:53 | Dont tell the FDA it's a fraud ffs | saint in exile | |
29/2/2024 21:34 | I'm not sure what people expect. This is an early stage pharma with no revenue currently. They have to raise money through the markets to fund research and development. Why is that so surprising/disappoin | orchestralis | |
29/2/2024 18:06 | Over on the lse forums it is like something I never seen before in how excited the posters was about BOIL and HEMO before these dreaded placing come along. I wouldn't be surprised if at least one has not hung themselves. It must be so depressing all this disappointment on top of disappointment for them. It's bad enough for me loosing 40k that is hopefully going to recover some of it soon. | luckyabbeygale | |
29/2/2024 17:34 | Vlad is a deceiver and Fraudster, He has been doing this to the shareholders for many many years. Artificially pumping price with Lies and than raising funds via placing to pay his and his crook team huge salaries. | trader4ever | |
29/2/2024 14:15 | Absolutely spot on Paul, time and time again this happens to the unwary investor and it's scandalous how easy it is to get away with it. Some of the financial press are complicit in this - on a regular basis. Perhaps they are plain lazy and don't do any research before they write a glowing article for a company promote - or perhaps they are just interested in any old story and just haven't got a conscience. Perhaps they don't have any financial experience at all and are just as unwary as some PIs. My tactic now is that if there is a sudden concerted effort by a co. to ramp its share price and its balance sheet is low on cash then if I'm holding the share I sell into the price spike - more often than not there's a fund raise coming soon. Fundraises Generally A pattern seems to be emerging, where speculative companies run out of cash, then they pump the share price with upbeat-sounding RNSs. Shortly afterwards they announce a discounted placing into any subsequent share price rise. Private investors speculating on these shares, buying the price rises, seem to be lambs to the slaughter. It doesn't seem right to me that shares are still trading, when the company is secretly offering discounted shares to larger investors in placings. It's often obvious from the share price that news has leaked. We really do need the rules changed (and/or enforced), so that shares are suspended when any company decides to do a fundraise. Also we need quicker, cheaper mechanisms for companies to raise cash. In the meantime, there's a simple way to avoid being clobbered by a discounted placing - don't buy or hold any share where the company doesn't have a cash runway of well over 12 months. Ideally investments should be companies which are profitable and cash generative, hence won't ever need to raise more cash just to keep the lights on. Jam tomorrow/ blue sky shares are a graveyard for optimistic investors, avoiding these things has been the biggest boost for my personal portfolio returns. That said, the odd one multibags, which is what excites people. | apotheki | |
29/2/2024 14:15 | Vlad is a deceiver, He has been doing this to shareholders for many many years. | trader4ever | |
29/2/2024 11:34 | Jibba, I`m with you on that, in the next month or two I can see 1.5p, very little confidence left in this company! | trek3 | |
29/2/2024 11:27 | This will bounce again on the next news. | orchestralis | |
29/2/2024 11:13 | Not at all Jibba Jabber as I for one really appreciate your honest approach which is most refreshing I must say. On the other hand I am now buying again sub the placing price so sub 2p. Anyways each to their own I guess. | apotheki | |
29/2/2024 11:07 | Keeping powder dry, i know this comment won't be welcome by holders but i see a 1.5p ish buying opp. | jibba jabber | |
29/2/2024 10:56 | Sorry for the long term holders. Vlad cannot be trusted he has shown time and time again. | trying2trade | |
29/2/2024 10:31 | That was my thought too. | countbasie1 | |
29/2/2024 10:31 | Jayrh You are confused. I didn't ask that question. | countbasie1 | |
29/2/2024 10:16 | You asked what the money would be used for and it tells you in the rns. Clinical trials money is another story | jayrh | |
29/2/2024 09:50 | Perhaps it is just a bit too early now but not for phases 2 & 3 | apotheki | |
29/2/2024 09:48 | Or alternatively a major industry players joins the party with a gift of mega bucks? | apotheki |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions